Healthcare

Investor may be FDA pick

By Robert King
Published December 7, 2016 7:40pm ET
Add Washington Examiner on Google
Investor may be FDA pick
President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File) | Andrew Harnik

The head of an investment firm co-founded by a major Trump supporter is under consideration to be President-elect Trump’s pick to lead the Food and Drug Administration.

Jim O’Neill, the managing director of the investment firm Mithril Capital, is being considered, according to multiple reports. The investment firm was co-founded by Trump supporter and Silicon Valley billionaire Peter Thiel.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Biden Transition Donald Trump FDA Minusextra Robert King